A Potential Therapeutic Strategy for Malignant Mesothelioma with Gene Medicine
Malignant mesothelioma, closely linked with occupational asbestos exposure, is relatively rare in the frequency, but the patient numbers are going to increase in the next few decades all over the world. The current treatment modalities are not effective in terms of the overall survival and the quali...
Main Authors: | Yuji Tada, Hideaki Shimada, Kenzo Hiroshima, Masatoshi Tagawa |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2013-01-01
|
Series: | BioMed Research International |
Online Access: | http://dx.doi.org/10.1155/2013/572609 |
Similar Items
-
Diffuse pleural thickening and thoracic contraction: An indistinguishable case from malignant pleural mesothelioma
by: Yuji Tada, et al.
Published: (2020-08-01) -
Metformin produces growth inhibitory effects in combination with nutlin-3a on malignant mesothelioma through a cross-talk between mTOR and p53 pathways
by: Kengo Shimazu, et al.
Published: (2017-05-01) -
An MDM2 inhibitor achieves synergistic cytotoxic effects with adenoviruses lacking E1B55kDa gene on mesothelioma with the wild-type p53 through augmenting NFI expression
by: Thao Thi Thanh Nguyen, et al.
Published: (2021-07-01) -
A Possible Anticancer Agent, Type III Interferon, Activates Cell Death Pathways and Produces Antitumor Effects
by: Masatoshi Tagawa, et al.
Published: (2011-01-01) -
Zoledronic acid produces combinatory anti-tumor effects with cisplatin on mesothelioma by increasing p53 expression levels.
by: Shinya Okamoto, et al.
Published: (2013-01-01)